Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 0 open-market purchases and 9 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Charles River Laboratories International, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 629 | 10 | 583 | −36 |
| Shares | 48.7M | 14.6K | 50.3M | +1.62M (+3.3%) |
| Value | $10.4B | $3.33M | $9.91B | −$524.5M (−5.0%) |
10 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (64)
Institutions that held Charles River Laboratories International, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (100)
Institutions that held Charles River Laboratories International, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (10)
Institutions that held Charles River Laboratories International, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sciencast Management LP | 5,297 | $1.31M |
| Icon Wealth Partners, LLC | 3,076 | $658.0K |
| Advisor Partners LLC | 1,790 | $383.0K |
| Pinnacle Private Wealth, LLC | 1,599 | $342.0K |
| HighPoint Advisor Group LLC | 1,416 | $320.0K |
| Coldstream Capital Management Inc | 1,089 | $233.0K |
| Brewin Dolphin Ltd | 202 | $43.0K |
| Private Capital Group, LLC | 97 | $21.0K |
| Brewin Dolphin Wealth Management Ltd | 65 | $14.0K |
| Fieldpoint Private Securities, LLC | 15 | $3.00K |